Our lab aims to understand the molecular mechanisms linking chronic skin inflammatory conditions, such as psoriasis and metabolic dysfunction. We have a particular interest in studying epigenetic regulation and structural-immune cell crosstalk. This work will provide new mechanistic insights for novel therapeutic intervention for patients with chronic skin inflammatory conditions and type 2 diabetes.